Fund Holdings — DIADEMA PARTNERS LP

Total Portfolio Value:
$125.15M
Total Bought:
$101.20M
Total Sold:
$63.32M
Net Transaction:
+$37.87M
Notable People:
Timothy Beau Bassett
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Regeneron Pharmaceuticals, Inc.(REGN)029,828+29,828$0$18.92M15.12%+$18.92M
Eli Lilly and Company(LLY)019,302+19,302$0$15.94M12.74%+$15.94M
Jazz Pharmaceuticals plcSHS USD(JAZZ)14,71987,189+72,470$1.81M$10.82M8.65%+$9.01M
TG Therapeutics, Inc.(TGTX)47,805207,883+160,078$1.44M$8.20M6.55%+$6.76M
argenx SEADR(ARGX)67912,279+11,600$422.0K$7.18M5.74%+$6.76M
Neurocrine Biosciences, Inc.(NBIX)062,247+62,247$0$6.88M5.50%+$6.88M
Soleno Therapeutics Inc71,98893,002+21,014$3.24M$6.64M5.31%+$3.41M
BioMarin Pharmaceutical Inc.(BMRN)052,877+52,877$0$3.74M2.99%+$3.74M
Alnylam Pharmaceuticals, Inc.(ALNY)013,115+13,115$0$3.54M2.83%+$3.54M
Vaxcyte, Inc.(PCVX)10,00092,385+82,385$818.6K$3.49M2.79%+$2.67M
Immunocore Holdings plcADS(IMCR)096,984+96,984$0$2.88M2.30%+$2.88M
Rhythm Pharmaceuticals, Inc.(RYTM)75,00050,000-25,000$4.20M$2.65M2.12%-$1.55M
Springworks Therapeutics Inc060,000+60,000$0$2.65M2.12%+$2.65M
Viking Therapeutics, Inc.(VKTX)0104,121+104,121$0$2.51M2.01%+$2.51M
Centessa Pharmaceuticals PlcADS131,862164,048+32,186$2.21M$2.36M1.88%+$150.3K
Cogent Biosciences, Inc.(COGT)90,000392,213+302,213$702.0K$2.35M1.88%+$1.65M
Viridian Therapeutics, Inc.(VRDN)49,478162,063+112,585$948.5K$2.18M1.75%+$1.24M
Scholar Rock Holding Corporation(SRRK)53,16057,923+4,763$2.30M$1.86M1.49%-$435.4K
89bio Inc0231,436+231,436$0$1.68M1.34%+$1.68M
Novo Nordisk A/SADR(NVO)024,618+24,618$0$1.68M1.34%+$1.68M
Kalvista Pharmaceuticals Inc0135,509+135,509$0$1.56M1.25%+$1.56M
Apogee Therapeutics Inc50,62040,000-10,620$2.29M$1.49M1.19%-$798.7K
Sage Therapeutics Inc0183,466+183,466$0$1.46M1.17%+$1.46M
Vistagen Therapeutics, Inc.(VTGN)442,520565,975+123,455$1.31M$1.41M1.13%+$109.5K
Ascendis Pharma A/SADR(ASND)25,2768,321-16,955$3.48M$1.30M1.04%-$2.18M
Trevi Therapeutics, Inc.(TRVI)0180,000+180,000$0$1.13M0.90%+$1.13M
Relay Therapeutics, Inc.(RLAY)505,778426,346-79,432$2.08M$1.12M0.89%-$966.8K
Pacira BioSciences, Inc.(PCRX)038,926+38,926$0$967.3K0.77%+$967.3K
UroGen Pharma Ltd.(URGN)50,00076,220+26,220$532.5K$843.0K0.67%+$310.5K
Climb Bio, Inc.(CLYM)374,423669,803+295,380$674.0K$817.2K0.65%+$143.2K
Cytokinetics, Incorporated(CYTK)020,000+20,000$0$803.8K0.64%+$803.8K
Replimune Group, Inc.(REPL)114,00074,530-39,470$1.38M$726.7K0.58%-$653.9K
Reviva Pharmaceutcls Hldgs I0650,723+650,723$0$620.7K0.50%+$620.7K
Alector Inc239,019456,546+217,527$451.7K$561.6K0.45%+$109.8K
uniQure N.V.SHS(QURE)036,500+36,500$0$386.9K0.31%+$386.9K
Olema Pharmaceuticals, Inc.(OLMA)0100,000+100,000$0$376.0K0.30%+$376.0K
Gossamer Bio, Inc.(GOSS)217,987269,589+51,602$197.2K$296.5K0.24%+$99.4K
Proqr Thrapeutics N VSHS EURO
SHS EURO
158,023207,694+49,671$418.8K$276.2K0.22%-$142.5K
Eledon Pharmaceuticals, Inc.(ELDN)75,79464,613-11,181$312.3K$219.0K0.18%-$93.2K
Mereo BioPharma Group plcADS(MREO)0492,215+492,215$0$168.5K0.13%+$168.5K
Terns Pharmaceuticals Inc50,37056,098+5,728$279.1K$154.8K0.12%-$124.2K
Sagimet Biosciences Inc.COM SER A(SGMT)046,019+46,019$0$150.0K0.12%+$150.0K
Candel Therapeutics, Inc.(CADL)20,00025,045+5,045$173.6K$141.5K0.11%-$32.1K
AbbVie Inc.(ABBV)50,0000-50,000$8.88M$0—-$8.88M
ALX Oncology Holdings Inc.(ALXO)197,6800-197,680$330.1K$0—-$330.1K
Aptevo Therapeutics Inc4,0500-4,050$17.5K$0—-$17.5K
Arcellx Inc
COMMON STOCK
10,1000-10,100$774.6K$0—-$774.6K
Arcus Biosciences, Inc.(RCUS)165,9650-165,965$2.47M$0—-$2.47M
AstraZeneca PLCADR(AZN)30,0000-30,000$3.93M$0—-$3.93M
BeOne Medicines AGADR(ONC)30,0000-30,000$421.7K$0—-$421.7K
BioNTech SEADS(BNTX)8,7670-8,767$999.0K$0—-$999.0K
Blueprint Medicines Corp64,1930-64,193$5.60M$0—-$5.60M
Bristol-Myers Squibb Company(BMY)160,0000-160,000$9.05M$0—-$9.05M
Chimerix Inc29,0820-29,082$101.2K$0—-$101.2K
Crinetics Pharmaceuticals In25,9000-25,900$1.32M$0—-$1.32M
Denali Therapeutics Inc.(DNLI)60,0000-60,000$1.22M$0—-$1.22M
Edgewise Therapeutics, Inc.(EWTX)1,3590-1,359$36.3K$0—-$36.3K
Erasca, Inc.(ERAS)156,9730-156,973$394.0K$0—-$394.0K
Evolus, Inc.(EOLS)97,4230-97,423$1.08M$0—-$1.08M
Geron Corporation(GERN)200,0000-200,000$708.0K$0—-$708.0K
GH Research PLC(GHRS)101,5020-101,502$710.5K$0—-$710.5K
Insmed Incorporated(INSM)56,3370-56,337$3.89M$0—-$3.89M
Keros Therapeutics, Inc.(KROS)63,5470-63,547$1.01M$0—-$1.01M
Larimar Therapeutics, Inc.(LRMR)3,8000-3,800$14.7K$0—-$14.7K
Lava Therapeutics NvSHS21,5080-21,508$20.5K$0—-$20.5K
Mind Medicine Mindmed Inc4,7100-4,710$32.8K$0—-$32.8K
Nektar Therapeutics(NKTR)698,9190-698,919$650.0K$0—-$650.0K
Nuvalent Inc14,7010-14,701$1.15M$0—-$1.15M
ORIC Pharmaceuticals, Inc.(ORIC)214,2910-214,291$1.73M$0—-$1.73M
Q32 Bio Inc.(QTTB)19,7000-19,700$67.8K$0—-$67.8K
SAB Biotherapeutics, Inc.(SABS)30,0000-30,000$113.8K$0—-$113.8K
Tarsus Pharmaceuticals, Inc.(TARS)60,0000-60,000$3.32M$0—-$3.32M
Teva Pharmaceutical Industries LimitedADS(TEVA)300,0000-300,000$6.68M$0—-$6.68M
Zevra Therapeutics, Inc.(ZVRA)42,0810-42,081$351.0K$0—-$351.0K
Page 1 of 1
DIADEMA PARTNERS LP — 13F Holdings — Q1 2025 | TickerTrail